Vimarsana
Biggest News Aggregation in the World

Bionic Sight News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bionic Sight. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bionic Sight Today - Breaking & Trending Today

Restoring sight is possible now with optogenetics - Vimarsana News

Restoring sight is possible now with optogenetics

As a child, Max Hodak learned to develop film in a darkroom with his grandfather who was almost blind.

Former Neuralink President Launches Eye Implants For The Blind - Vimarsana News

Former Neuralink President Launches Eye Implants For The Blind

A start-up company in Alameda, California called Science has designed a visual prosthesis called the Science Eye that could restore vision in people with retinitis pigmentosa, according to a recent report.

Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 - Vimarsana News

Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034

/PRNewswire/ -- DelveInsight's Stargardt Disease Market Insights report includes a comprehensive understanding of current treatment practices, Stargardt...

Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 - Vimarsana News

Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034

/PRNewswire/ -- DelveInsight's Usher Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, Usher syndrome...

Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 | DelveInsight - Vimarsana News

Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 | DelveInsight

According to DelveInsight’s analysis, the growth of the gene therapies market in ophthalmology is expected to be mainly driven by the increasing prevalence of eye disease, rise in awareness and access to treatment, increased adoption of enhanced genetic testing and robust pipeline activity for eye disease in the 7MM.  LAS VEGAS, April 4, 2024 /PRNewswire/ […]